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Mycobacterium ulcerans and Mycobacterium marinum are closely related pathogens which share an aquatic
environment. The pathogenesis of these organisms in humans is limited by their inability to grow above 35°C.
M. marinum causes systemic disease in fish but produces localized skin infections in humans. M. ulcerans
causes Buruli ulcer, a severe human skin lesion. At the molecular level, M. ulcerans is distinguished from M.
marinum by the presence of a virulence plasmid which encodes a macrolide toxin, mycolactone, as well as by
hundreds of insertion sequences, particularly IS2404. There has been a global increase in reports of fish
mycobacteriosis. An unusual clade of M. marinum has been reported from fish in the Red and Mediterranean
Seas and a new mycobacterial species, Mycobacterium pseudoshottsii, has been cultured from fish in the
Chesapeake Bay, United States. We have discovered that both groups of fish pathogens produce a unique
mycolactone toxin, mycolactone F. Mycolactone F is the smallest mycolactone (molecular weight, 700) yet
identified. The core lactone structure of mycolactone F is identical to that of M. ulcerans mycolactones, but a
unique side chain structure is present. Mycolactone F produces apoptosis and necrosis on cultured cells but
is less potent than M. ulcerans mycolactones. Both groups of fish pathogens contain IS2404. In contrast to M.
ulcerans and conventional M. marinum, mycolactone F-producing mycobacteria are incapable of growth at
above 30°C. This fact is likely to limit their virulence for humans. However, such isolates may provide a
reservoir for horizontal transfer of the mycolactone plasmid in aquatic environments.
Mycobacterium marinum is a globally distributed pathogen
of marine and freshwater fish which also causes skin infections
in humans (7, 9). M. marinum is phenotypically distinguished
from other mycobacteria by its low optimal growth tempera-
ture, light-induced carotenoid production, and relatively rapid
growth rate compared to other slow-growing Mycobacterium
species. There is considerable heterogeneity among M. mari-
num isolates, and several subgroups have been described (28,
33–35).
Mycobacteriosis was first diagnosed in fish from the Red Sea
in 1990 (5). The infection was initially found in cultured sea
bass (Dicentrarchus labrax) in Eilat and has since been found in
over 20 different fish species and a hawksbill sea turtle. The
Red Sea isolates differed phenotypically from other M. mari-
num strains by being scotochromogenic (having constitutive
pigment production). Whereas most M. marinum strains form
colonies on mycobacterial media within 8 days, initial growth
was not obtained from these isolates for at least 2 weeks.
Similar isolates have also been found in the Mediterranean Sea
in Greece and Italy. Molecular characterization of the Israeli
isolates from fish confirmed their identity as M. marinum, but
analysis of the 16S rRNA gene showed that the isolates formed
clades within the species (33, 34). Molecular comparison of the
fish isolates with human isolates of M. marinum from Israel
showed that human and fish isolates fell into discrete groups
based on 16S rRNA, hsp65, and AFLP patterns (34). Human
isolates were designated A strains, whereas fish isolates were
placed in the B group. Within group B, marine isolates (B1)
could be distinguished from freshwater isolates (B2). A grow-
ing number of similar M. marinum strains have been isolated
from marine fish in various locations along the Mediterranean
coast (Italy, Israel, and Greece) as well as from fish from other
aquatic environments in Israel.
The Red Sea M. marinum strain is the only mycobacterial
species detected in the marine environment in Israel and is
associated with unusually severe pathology. Though cutaneous
lesions are not always present, the spleens and kidneys of
diseased fish are riddled with granulomas containing massive
numbers of acid-fast bacilli (Fig. 1). The Israeli marine strain
was first isolated from cultured sea bass (Dicentrarchus labrax),
but many Red Sea species appear to be susceptible to infection
(5, 8, 33).
Newly emerging mycobacterial fish pathogens from the
Chesapeake Bay in the United States have also been reported
(15, 25). In 2005 a new mycobacterial species, Mycobacterium
pseudoshottsii, was described in association with epizootic fish
disease among striped bass (Morone saxatilis) in the Chesa-
peake Bay, Maryland. Molecular analysis showed that the 16S
rRNA gene from M. pseudoshottsii was greater than 99% sim-
ilar to that of an Israeli marine M. marinum isolate, DL240490
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(25). M. pseudoshottsii was reported to be closely related to M.
marinum, to the human pathogen Mycobacterium ulcerans, and
to a newly described frog pathogen, Mycobacterium liflandii
(24). It was of particular interest that M. pseudoshottsii, like M.
liflandii, contained an insertion sequence, IS2404, previously
found only in M. ulcerans and in an atypical M. marinum strain
isolated from a human patient (25, 30).
DNA-DNA hybridization and multilocus sequence analysis
show that M. marinum is extremely closely related to M. ulcer-
ans (28, 31). The two species share 99.8% identity within the
16S rRNA gene, and a growing body of evidence suggests that
M. ulcerans evolved relatively recently from an M. marinum
ancestor (29). Two major events have been associated with the
evolution of M. ulcerans. One is acquisition of a plasmid-en-
coded macrolide toxin, mycolactone, and the second is major
genome remodeling associated with insertion of over 300 cop-
ies of two insertion sequences, IS2404 and IS2606. Acquisition
of these IS elements has created a large number of pseudo-
genes in M. ulcerans, leading to the hypothesis that M. ulcerans
is adapting to a specialized niche (http://genopole.pasteur.fr
/Mulc/BuruList.html).
Despite the close taxonomic relationship, M. marinum and M.
ulcerans produce distinctly different diseases (7, 9). Whereas M.
marinum causes a granulomatous intracellular infection in fish
and humans, M. ulcerans produces an extracellular infection,
Buruli ulcer, characterized by severe tissue destruction and the
presence of few inflammatory cells at the site of infection (2, 6,
20, 36). Genetic evidence with mycolactone-negative mutants
suggests that mycolactone is responsible for the unique char-
acteristics of Buruli ulcer (1, 12). Recently a second mycolac-
tone-producing mycobacterial pathogen, M. liflandii, was iso-
lated from Xenopus tropicalis and Xenopus laevis frogs in U.S.
laboratories (24, 32). This organism is also closely related to M.
marinum and M. ulcerans.
Mycolactone is a hybrid polyketide composed of a lactone
core and a fatty acid side chain (14). All strains of M. ulcerans
produce a major mycolactone species along with several minor
congeners (4, 16, 23). The first mycolactones were isolated
from a Malaysian isolate of M. ulcerans as a 3:2 mixture of two
stereoismers designated mycolactone A/B (14). Since then it
has been shown that all African and Malaysian isolates of M.
ulcerans produce identical molecules. However, there is hetero-
geneity in the mycolactones produced by M. ulcerans from
different geographic areas. M. ulcerans strains isolated in Aus-
tralia produce a different mycolactone, mycolactone C,
whereas Asian isolates of M. ulcerans produce primarily my-
colactone D (23). A novel plasmid-encoded mycolactone, my-
colactone E, has been recently identified in the frog pathogen
M. liflandii (23). The large polyketide synthase genes for my-
colactone biosynthesis comprise a 110-kb gene cluster on a
large (154- to 180-kb) plasmid (29). The lactone core structure,
encoded by mlsA, is conserved in all mycolactones. Molecular
diversity has arisen through modifications of the fatty acid side
chain structure encoded by mlsB.
Despite the structural heterogeneity, all mycolactone species
produce apoptosis and necrosis in cultured cells (1, 13, 26).
Mycolactone A/B is the only mycolactone evaluated in vivo. In
guinea pig and mouse infection models as well as in human
infection, mycolactone A/B causes apoptotic cell death as well as
death via necrosis (1). In addition, in humans and guinea pigs,
mycolactone is associated with immunosuppression (36, 37).
The close taxonomic relationship of an Israeli M. marinum
isolate (DL240490) to M. pseudoshottsii, the relationship of
these species to M. ulcerans, and the shared association with
aquatic environments led us to investigate further the relation-
ship of M. pseudoshottsii and Israeli fish isolates to M. ulcerans.
Results from these studies show that M. marinum strains iso-
lated from fish in several locations in the Mediterranean and
Red Seas as well as M. pseudoshottsii strains isolated from fish
in the Chesapeake Bay produce a plasmid-encoded mycolac-
tone. Despite the wide geographic separation of mycolactone-
producing M. marinum and M. pseudoshottsii, both groups of
organisms produce an identical mycolactone, designated my-
colactone F.
MATERIALS AND METHODS
Histology. Fish were trapped, euthanatized, and dissected within 48 h. Dis-
sected tissue was fixed with buffered neutral formalin, dehydrated in ethanol, and
embedded in paraffin. Paraffin blocks were sectioned and stained with Ziehl-
Neelsen stain as described previously (8).
Strains and growth conditions. Strains and their sources are shown in Table 1.
All isolates were grown on Middlebrook 7H10 agar medium supplemented with
10% oleic acid, dextrose, and albumin supplement or on Bordet-Gengou me-
dium. M. ulcerans strains were incubated at 32°C. All other isolates were grown
at room temperature (RT). For determination of optimal growth temperature,
mycobacterial isolates were grown at 32°C and RT (23 to 25°C). For determi-
nation of pigment production, isolates were grown initially in the dark and
exposed to light for 2 h. Plates were subsequently returned to the dark to prevent
degradation of mycolactones.
Mycolactone isolation. Lipids were extracted from M. ulcerans with chloro-
form-methanol (2:1, vol/vol), and phospholipids were removed by precipitation
with ice-cold acetone to obtain acetone-soluble lipids (ASLs). Purified mycolac-
tone was obtained using centripetal silica chromatography with a chromatotron
as previously described (11, 24). ASLs were analyzed by thin-layer silica chro-
matography using the solvent system chloroform-methanol-water (90:10:1, vol/
vol/vol) and visualized by charring with ceric sulfate-ammonium molybdate in
2 M sulfuric acid (24).
Cell culture and cytopathicity assays. L929 mouse fibroblasts (ATCC CCL1)
were purchased from the American Type Culture Collection and maintained in
the lab in Dulbecco’s minimal Eagle medium with 5% fetal calf serum and 1
L-glutamine in tissue culture flasks incubated in 5% CO2 at 37°C as previously
described (1). ASL samples or individual lipid species were diluted in tissue
culture medium and added to cells in a 96-well tissue culture plate to determine
cytopathicity. In addition, intact bacteria and culture filtrate were directly added
to cells in serial dilutions to evaluate the cytopathic capacity of surface-exposed
and secreted mycolactone. Cytopathicity was defined as the minimal concentra-
tion of ASL or mycolactone necessary to produce cell rounding in 24 h and loss
of the monolayer by 48 h (1, 11).
PCR. Fifty-microliter reaction mixtures containing 15.5 l double-distilled
water, 25 l Failsafe PCR 2 PreMix G (Epicenter) (50 mM Tris-HCl [pH 8.3,
22°C], 50 mM KCl, 200 M of each deoxynucleoside triphosphate, and propri-
etary amounts of FailSafe PCR enhancer and MgCl2 per reaction), 1 M of each
FIG. 1. Pathology showing infection with M. marinum DL240490 in
sea bass (Dicentrarchus labrax) from an outbreak of mycobacterial
disease in the Red Sea. (A) Severe splenomegaly and granulomatous
spleen and kidney. (B) Massive load of acid-fast bacilli (Ziehl-Neelsen
staining) within a splenic granuloma (total magnification, 100).
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primer, 1.25 U Failsafe PCR enzyme mix (Epicenter), and 7 l template derived
from whole-cell boiled preparations were prepared. Cycling was performed in a
Mastercycler gradient thermal cycler (Eppendorf) as follows: 98°C for 5 min; 35
cycles of 98°C for 1 min, 55°C for 1 min, and 72°C for 1 min; and 72°C for 10 min.
Nine microliters of each reaction mixture was analyzed on 1 to 1.5% agarose gels
in 1 Tris-acetate-EDTA stained with 1 g/ml ethidium bromide.
Gene probing included the following: repA, 5-TGGACCGGTCCTCAGTAA
CC-3 and 5-ATCGACGCTCGCTACTTCTG-3; mlsA, as described previously
(23); mlsB, 5-CAGCCAACTGCGCTACTACA-3 and 5-AGGAGACACGG
TTGGCTATG-3; MUP045, as described previously (23); MUP053, 5-ACCC
ACCTCGTCGTTAGTCATG-3 and 5-CGCAGAGTTCGAGTATCACGTCT
AT-3; IS2404 and IS2606, as described previously (26); uhp-1, 5-GCACCGA
CGACGAGCTTCTT-3 and 5-GGCCGAGCATCTCAATCTCC-3; uhp-2,
5-GCGGAGTTCCACATCACGAC-3 and 5-ACCGGCTGAGGATCGAAT
TG-3; chp, 5-CGATCCACCACGACTTCACG-3 and 5-CAATTCCATGTG
CGCCTCTG-3; zinc, 5-GAGCGGGAAATGGTCACTGG-3 and 5-GCGCT
GTTCCCAATCCTCCT-3; uhp-mem, 5-ACCCAGGATGAGCGAACACC-3
and 5-TGGCTGAGTTTCGGGTCCAT-3; and esxA and esxB, as described
previously (24).
DNA sequencing. PCR products were cloned into the pCR2.1-Topo vector
(Invitrogen) and sequenced using an ABI 3100 automated genetic analyzer
(Applied Biosystems, Inc.) and the ABI Big Dye Terminator 3.1 cycle sequencing
kit (Applied Biosystems, Inc.).
LDH release and apoptosis. L929 fibroblasts and peripheral blood neutrophils
were assayed for cell death via apoptosis and necrosis. Cytotoxicity/necrosis was
measured using a colorimetric kit from Promega as described previously (1).
Briefly, cells suspended in Dulbecco’s minimal Eagle medium supplemented with
5% (fibroblasts) or 10% (neutrophils) fetal calf serum and 1 L-glutamine were
seeded in triplicate at a concentration of 104 cells/well in a 96-well plate. The
release of cytoplasmic lactate dehydrogenase (LDH) from mycolactone-treated
(15 ng, 150 ng, 1.5 g, and 15 g), permeabilized cells was measured at 24 h
postinfection by using the colorimetric kit from Promega according to the man-
ufacturer’s instructions. Background release of LDH was obtained by measure-
ment of ethanol-treated cells, and maximum release of LDH was obtained by
lysis of untreated cells according to the manufacturer’s protocol. The percent LDH
release was then determined using the following calculation: [(release of LDH from
mycolactone-treated cells  background release from ethanol-treated cells)/(maxi-
mum release of LDH by cell lysis  background release)]  100.
Apoptosis of mycolactone-treated neutrophils and fibroblasts was measured at
24 h posttreatment by using the Cell Death Detection Plus enzyme-linked im-
munosorbent assay (Roche, Indianapolis, IN) as described previously (1). Apop-
tosis was then determined as fold enrichment of nucleosomes [(measurement of
DNA-histone complex from treated cells/background measurement of untreated
cells)].
HPLC and MS. Methanolic extracts of ASLs were analyzed using Shimadzu
LC-20AD analytical high-pressure liquid chromatography (HPLC) with UV de-
tection at 360 nm. Separation of various mycolactones was obtained on a Phe-
nomenex-Luna C18 250- by 4.6-mm column at a flow rate of 2 ml/min with a
water-acetonitrile gradient (55% acetonitrile for 3 min [isocratic] followed by a
37-min linear gradient to100% acetonitrile). UV-active fractions were analyzed
offline on an ion trap ESI Bruker-Esquire mass spectrometer (MS). MS analysis
conditions were as follows: dry temperature of 300°C, gas flow of 5 liters/min, and
nebulizer pressure of 15 lb/in2. For preliminary screening, the methanolic ex-
tracts of ASLs were directly analyzed without chromatographic separation.
NMR. Two milligrams of previously purified mycolactone F was dissolved in
CD3COCD3 (500 l). 1H nuclear magnetic resonance (NMR) and two-dimen-
sional (2D) spectroscopy (COSY) spectra were recorded on a Varian INOVA
spectrometer at 500 MHz. Chemical shifts were reported in ppm relative to the
residual acetone peak at 2.09 ppm.
Nucleotide sequence accession numbers. M. pseudoshottsii L15 mycolactone
gene sequences have been deposited in the GenBank database under the fol-
lowing accession numbers: mlsA (enoyl reductase), DQ508258; mlsB (loading
module), DQ508257; and MUP045 (fabH-like “joinase”), DQ508256. M. marinum
DL240490 mycolactone gene sequences have been deposited in the GenBank
database under the following accession numbers: mlsA, DQ508261; mlsB,
DQ508260; and MUP045, DQ508259.
TABLE 1. Mycobacterial strains used for this study, grouped by species
Strain Species Host Geographic origin Reference orsource
Agy99 M. ulcerans Human Ghana 29
1615 M. ulcerans Human Malaysia ATCCa 35840
V2 M. ulcerans Human Australia 23b
753 M. shinshuense Human Japan 18
XL5 M. liflandii Frog (Xenopus laevis) University of Virginia 24
L6 M. pseudoshottsii Striped bass (Morone saxatilis) Chesapeake Bay 25
L15 M. pseudoshottsii Striped bass (Morone saxatilis) Chesapeake Bay 25
L21 M. pseudoshottsii Striped bass (Morone saxatilis) Chesapeake Bay 25
L23 M. pseudoshottsii Striped bass (Morone saxatilis) Chesapeake Bay 25
L50 M. pseudoshottsii Striped bass (Morone saxatilis) Chesapeake Bay 25
1218 M. marinumc Salt water fish Philadelphia, Pa. ATCC 927
M M. marinumc Human San Francisco, Calif. ATCC BAA-535
DL/DK1 M. marinumc Sea bass (Dicentrarchus labrax) Denmark 33
DL240490 M. marinumd Sea bass (Dicentrarchus labrax) Red Sea, Israel 33
DL150991 M. marinumd Sea bass (Dicentrarchus labrax) Mediterranean Sea, Israel 33
DL180892 M. marinumd Sea bass (Dicentrarchus labrax) Ein Yahav, Israel 34
045 Thalassa M. marinumd Sea bass (Dicentrarchus labrax) Mediterranean Sea, Greece 33
DL241200 M. marinumd Sea bass (Dicentrarchus labrax) Mediterranean Sea, Greece This work
DL300/04 M. marinumd Sea bass (Dicentrarchus labrax) Mediterranean Sea, Italy This work
DL272/05 M. marinumd Sea bass (Dicentrarchus labrax) Mediterranean Sea, Italy This work
CF030494 M. marinumd Butterflyfish (Chaetodon fasciatus) Red Sea, Israel 33
SA200695 M. marinumd Sea bream (Sparus aurata) Red Sea, Israel 33
Hybrid270995 M. marinumd Red sea bream (Pagrus major female) 
Sparus aurata male)
Red Sea, Israel 33
SV300500 M. marinumd Lizard fish (Synodus variegatus) Red Sea, Israel 33
SV061004 M. marinumd Lizard fish (Synodus variegatus) Red Sea, Israel This work
SR030597 M. marinumd Rabbitfish (Siganus rivulatus) Red Sea, Israel 33
CC240299 M. marinumd Koi (Cyprinus carpio) Ma’agan Michael, Israel 33
BB170200 M. marinumd Silver perch (Bidyanus bidyanus) Dor-Ma’agan Michael, Israel 32
a ATTC, American Type Culture Collection.
b The strain is named TS-2 in reference 23.
c M. marinum isolate displaying light-induced pigment production (photochromogenic).
d M. marinum isolate displaying constitutive pigment production (scotochromogenic).
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RESULTS
Israeli isolates of M. marinum from fish exhibit tempera-
ture-restricted growth. The fact that M. marinum and M. ul-
cerans grow poorly, if at all, above 35°C is thought to limit
infection in humans primarily to cutaneous lesions. In hospital
laboratories M. ulcerans and M. marinum are grown at 30 to
32°C. Furthermore, M. marinum strains isolated from fish as
well as from humans have been shown to grow readily at 30°C
(9, 35). In marine veterinary laboratories, however, including
that at Eilat, mycobacteria from fish are routinely grown at 23
to 25°C. Also, the fish pathogen M. pseudoshottsii has been
reported to be unable to grow at 30°C (25). Since the temper-
ature sensitivity of M. marinum isolated from fish in Israel had
not been reported, we investigated the ability of these strains
to grow above 25°C. M. ulcerans, M. marinum 1218, M. mari-
num DL/DK1, and M. marinum M grew readily at 32°C, a
temperature consistent with the growth temperature used in
clinical laboratories. The frog pathogen M. liflandii also grew at
32°C on M7H10 with oleic acid-albumin-dextrose complex.
However, M. marinum isolated from fish from the Red and
Mediterranean Seas showed more severe temperature-re-
stricted growth. For these isolates, no growth was observed
after 3 months of incubation at 32°C. The two freshwater
isolates from Israel, CC240299 and BB170200, produced very
scant growth at 32°C, suggesting that the growth temperature
ranges of these two isolates may be broader than those of the
Red Sea isolates. None of the five M. pseudoshottsii isolates
tested produced growth at 32°C.
The generation time of M. marinum is reported to be 4.5 h,
and colonies can be detected on solid medium within 7 to 10
days. M. marinum 1218 (fish, United States), M. marinum DL/
DK1 (fish, Denmark), and M. marinum M (human, United
States) formed colonies by 8 days at 32°C. However, M. mari-
num isolates from the Red and Mediterranean Seas did not
produce colonies for at least 14 days at RT. M. ulcerans, M.
liflandii, and M. pseudoshottsii required 4 weeks of incubation
at their optimal temperatures (32°C, 32°C, and 23 to 25°C,
respectively).
Pigment production in Israeli isolates is variable among
strains and is constitutive. Most M. marinum strains produce
large quantities of carotenoid pigments upon exposure to light.
Pigment production was variable among Israeli and other
Mediterranean strains tested. All of the 11 saltwater isolates
tested were deep yellow, consistent with carotenoid produc-
tion. However, pigment production occurred constitutively
without light induction (i.e., these strains were scotochromo-
genic). Colonies from freshwater isolates CC240299 and
BB170200 and two isolates from Italy, DL300/04 and DL272/
05, were very pale yellow. Analysis of chloroform-methanol
extracts by thin-layer chromatography (TLC) revealed the
presence of a major lipid species with a retention factor (Rf) of
0.71 in all strains which produced a deep-yellow pigment con-
sistent with carotenoid production (data not shown).
PCR analysis of M. marinum and M. pseudoshottsii for the
presence of mycolactone- and M. ulcerans-specific genes. All
Israeli and Mediterranean Sea isolates of M. marinum as well
as M. pseudoshottsii were positive for all mycolactone-associ-
ated genes except MUP053, suggesting that mycolactones from
these strains would not have a hydroxyl at C-12 on the fatty
acid side chain. DNA sequence comparisons of mlsA, mlsB,
and MUP045 from mycolactone-producing M. marinum
(MPMM) and M. pseudoshottsii with those from M. ulcerans
revealed greater than 99% homology for all three genes. In
contrast, these sequences could not be amplified from two M.
marinum fish isolates, DL/DK1 (Europe) and 1218 (United
States) or from the genome sequence strain for M. marinum
(strain M). M. marinum isolates obtained from human patients
in Israel (34) were PCR negative for all mycolactone-related
genes.
The availability of the M. ulcerans and M. marinum genome
sequence made it possible to further characterize MPMM and
M. pseudoshottsii isolates with respect to M. ulcerans- and M.
marinum-specific genes (T. P. Stinear et al., unpublished data).
A number of M. ulcerans genes, including the insertion se-
quences IS2404 and IS2606 as well as a few chromosomally
encoded loci, are present in the M. ulcerans genome strain,
Agy99, but absent in the M. marinum genome strain, strain M.
A further distinction between M. ulcerans and M. marinum is
that most M. ulcerans strains have undergone a 2.8-kb deletion
in RD1 (24), a region first defined in Mycobacterium tubercu-
losis (17, 21) which encodes a putative secretion apparatus
required for secretion of the small antigenic proteins Esat6
(esxA) and Cfp10 (esxB). Esat6 and Cfp10 play an important
role in the granulomatous response to M. marinum and M.
tuberculosis, and the absence of these genes in most M. ulcerans
strains may contribute to the diminished granulomatous re-
sponse to M. ulcerans infections.
IS2404 was detected in all MPMM and M. pseudoshottsii
isolates tested and was absent from the M. marinum 1218 and
M. marinum DL/DK1 isolates as well as the M strain. In con-
trast, IS2606 was not detected in the two MPMM isolates,
CC240299 and BB170200, obtained from freshwater fish but
was detected in all marine MPMM isolates. The majority of
“M. ulcerans-specific” genes were detected in MPMM and M.
pseudoshottsii isolates as well as in M. liflandii (Table 2). How-
ever, an M. ulcerans-specific hypothetical membrane protein
gene, uhp-mem, was lacking in all isolates of MPMM and M.
pseudoshottsii, and uhp-2, an M. ulcerans-specific phage se-
quence, was absent from M. liflandii and MPMM CC240299 and
BB170200. Finally, esxA and esxB were present in MPMM and
M. pseudoshottsii. The presence of esxA and esxB in MPMM
and M. pseudoshottsii might provide insight into the evolution-
ary relationship between these isolates and M. ulcerans.
MPMM and M. pseudoshottsii produce a unique mycolac-
tone. ASLs from 2:1 chloroform-methanol extracts of bacterial
pellets were analyzed by silica thin-layer chromatography for
the presence of polar lipid species typical of mycolactones. In
a chloroform-methanol-water (90:10:1, vol/vol/vol) solvent sys-
tem, M. ulcerans mycolactone A/B has an Rf of 0.29, whereas
M. liflandii mycolactone E has an Rf of 0.53. Silica TLC analysis
of lipids from 6 M. pseudoshottsii isolates and 15 MPMM iso-
lates showed that ASLs from all strains contained a putative
mycolactone species with an Rf of 0.43 (data not shown). Cy-
topathicity assays using L929 cells showed that this lipid spe-
cies caused cell rounding after 24 h and detachment at 48 h at
a concentration of less than 100 ng/ml, a phenotype consistent
with mycolactone activity. Cytopathicity was associated with
this lipid species in each strain tested. Addition of approxi-
mately 104 intact bacteria also produced this cytopathic effect,
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suggesting that this molecule, like other mycolactones, was
present on the cell surface. Finally, addition of sterile culture
filtrate elicited cytopathicity, suggesting that this molecule was
secreted as well as cell associated.
Identification of mycolactone F. Since all M. pseudoshottsii
isolates were phenotypically very similar, showed identical lipid
profiles by TLC, and were identical by PCR profiling, only L15,
the type strain for M. pseudoshottsii, was grown in quantity to
obtain sufficient mycolactone for detailed chemical analysis.
However, both phenotypic heterogeneity and molecular hetero-
geneity were detected within MPMM isolates. For this reason
mycolactones were purified from nine of them, representing
each of the major groups of isolates characterized by Ucko and
Colorni (34).
Previously identified mycolactones and cometabolites share
a conserved core structure, with variation only in the substitu-
tion of the side chain. Therefore, mass spectroscopy analysis of
ASLs has been a very useful tool in screening for new myco-
lactones. Mass spectroscopic analysis of M. pseudoshottsii L15
and the nine isolates of MPMM revealed a major ion at m/z
723 (MNa), suggesting the presence of a novel mycolactone,
which was designated mycolactone F (Table 3). The cytopathic
activity of this species for L929 cells was 10 ng/ml. This ion was
absent from M. marinum DL/DK1. Using ion trap MS/MS
analysis, the conserved lactone core can be detected as an M 
Na ion at m/z 429 that is produced upon fragmentation of the
parent mycolactone. Using this technique, we found that ASLs
of all of the MPMM and M. pseudoshottsii strains tested
showed a major positive ion at m/z 723 (M  Na) which upon
fragmentation produced the conserved core fragment ion at
m/z 429. Moreover, the fragmentation patterns in all samples
were identical, suggesting that the mycolactones produced by
these strains have the same chemical structure (Fig. 2). Deu-
terium exchange experiments concluded that mycolactone F has
only four hydroxyl groups, two of which are located in the side
chain. This is consistent with PCR data suggesting the absence of
MUP053, which is thought to produce a third hydroxyl group on
carbon 12 of the side chain of mycolactone A/B.
Most mycolactones exist as a mixture of double-bond iso-
mers and are isolated along with minor cometabolites. To
investigate this issue, reversed-phase HPLC analysis was per-
formed on the ASL extracts. Under the condition described,
the major isomer of mycolactone F was easily identifiable at a
TABLE 2. PCR results for other genes common to M. ulcerans and/or M. marinum
Species or control Strain
Insertion sequences Chromosomal genes of M. ulcerans but not M. marinuma Rd1 genesb
IS2404 IS2606 uhp-1c uhp-2c chpc zincc uhp-memd esxA esxB
M. ulcerans Agy99         
1615         
V2         
753         
M. liflandii XL5         
M. pseudoshottsii L15         
M. marinum 1218         
DL/DK1         
DL240490e         
DL150991e         
DL180892e         
045 Thalassae         
CF030494e         
SA200695e         
Hybrid270995e         
CC240299 f         
BB170200 f         
Double-distilled water         
a Based on comparative genomics of M. ulcerans Agy99 and M. marinum M strain (uhp, unique hypothetical protein gene; chp, conserved hypothetical protein gene;
zinc, putative zinc metalloprotease gene; uhp-mem, unique hypothetical membrane protein gene).
b Rd1 target genes esxA and esxB encode Esat6 and Cfp10, respectively.
c Genes found on prophage specific to M. ulcerans.
d Gene determined as M. ulcerans specific by subtractive hybridization.
e MPMM strain from salt water.
f MPMM strain from freshwater.
TABLE 3. Mycolactones identified in ASLs from 11 mycobacterial
strains isolated from diseased fish
Strain M  Na ionsidentified
M. ulcerans 1615..........................................................765a, 777, 779
M. pseudoshottsii L15..................................................723b, 739, 755, 763
M. marinum
DL240490.................................................................723, 739, 755, 763
DL180892.................................................................723, 739, 755, 763
DL150991.................................................................723, 739, 755, 757
DL045 Thalassa.......................................................723, 739, 763
CF030494 .................................................................723, 739, 755, 757
SA200695 .................................................................723, 739,755
Hybrid270995...........................................................723, 739, 757
BB170200 .................................................................723, 739, 755
CC240299.................................................................721, 723, 739, 755
DL/DK1....................................................................None observed
a m/z 765 (M  Na) represent the major positive ion of mycolactone A/B.
b m/z 723 (M  Na) represents the major positive ion of mycolactone F.
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retention time of 20.5  0.05 min (Fig. 3). Other geometric
isomers and minor cometabolites were also identified. HPLC
and MS/MS analysis confirmed that all strains produce the
same molecule. However, differences in stereochemistry, though
unlikely, cannot be ruled out by these methods.
Structural characterization of mycolactone F. Although
mass spectroscopy is an increasingly valuable tool for molecu-
lar analysis, data from NMR analysis provides a more rigorous
method for structural assignments. The limited amount of my-
colactone produced by mycobacterial species as well as the
very low growth rate of mycolactone-producing bacteria has
made it extremely difficult to obtain sufficient mycolactone for
optimal structural analysis. However, the relatively robust
growth yield of lipids from some MPMM isolates made it
possible to undertake a more thorough analysis of the myco-
lactone F structure. For these studies, 1D and 2D NMR ex-
periments were performed on purified mycolactone from M.
marinum DL240490. 1H NMR revealed a structure very similar
to that reported for mycolactone A/B, with the characteristic
core signals of protons at C-9, C-15, C-11, and C-5 easily
identified at 5.16, 5.03, 4.93, and 4.75 ppm, respectively (Fig. 4;
Table 4). In the region corresponding to the side chain, two
geometric isomers were distinguished, with an integration ratio
of 10 to 1. Both isomers showed five olefinic protons. For the
major isomer, the most downfield proton was that of C-3
which appeared as a doublet at 7.39 ppm and was coupled to
the C-2 proton (doublet at 5.91 ppm). The presence of two
singlet peaks at 6.4 and 6.1 ppm suggested methyl substitutions
at C-4, C-6, and C-8. This was confirmed by 2D COSY
analysis, which showed the long-range coupling of these ole-
FIG. 2. Mass spectroscopy of ASLs from mycolactone F-producing
M. marinum strains. (A) MS of ASLs from M. marinum DL240490,
showing the mycolactone F sodium adduct at m/z 723. (B to D) MS/MS
of the m/z 723 peak showing the core (*) and side chain (**) in M.
marinum DL180892 from the Red Sea (B), M. marinum 045 Thalassa
from the Mediterranean Sea (C), and BB170200 from a freshwater
pond, Israel (D). The MS/MS peak for m/z 723 from DL240490 was
identical to that shown for DL180892.
FIG. 3. Reverse-phase HPLC of ASLs derived from mycolactone
F-producing strains. (A) M. marinum DL240490; (B) M. pseudoshottsii
L15; (C) M. marinum SA200695; (D) M. marinum BB170200. The
major isomer of mycolactone F at a retention time of 20.5  0.05 min
is indicated with an asterisk.
FIG. 4. 1D H1 NMR spectrum of mycolactone F.
TABLE 4. Proton shifts relative to residual acetone for the two
major isomers of mycolactone F
Major isomer Minor isomer Conserved core
C Proton shift(ppm) C
Proton shift
(ppm) C
Proton shift(s)
(ppm)
1 1 1
2 5.91 (d) 2 5.94 (d) 2 2.45, 2.04
3 7.39 (d) 3 7.94 (d) 3 1.60
4 4 4 1.7
5 6.46 (s) 5 6.34 5 4.75
6 6 6 2.01
7 6.09 (s) 7 5.89 7 1.92
8 8 8
9 5.56 (t) 9 5.47 9 5.16
10 2.31 (m) 10 NDa 10 2.51, 2.12
11 3.99 11 ND 11 4.93
12 1.12 12 ND 12 2.09
13 3.56 13 ND 13 2.14, 1.9
14 1.03 14 ND 14
15 ND 15 2.05 15 5.03
16 2.03 16 1.97 16 2.39
17 2.06 17 1.98 17 3.5
18 1.62, 1.13
19 3.99
20 1.13
21 1.00
22 1.7
23 1.03
24 1.69
25 0.97
a ND, not determined.
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finic protons to methyl groups at 2.06 and 2.03 ppm. The remain-
ing side chain signals from C-10 to C-15 overlapped signals from
the mycolactone core in the 1D 1H NMR. Thus, 2D COSY was
used to assign these protons (C-9 to C-14), using the off-diag-
onal 1H-1H correlation peaks. Mycolactone F (Fig. 5) is the small-
est mycolactone so far identified. As with other mycolactone
variants, the core lactone structure is identical to that of other
mycolactones, whereas the side chain is unique.
Biological activities of mycolactone F. Mycolactones pro-
duce a distinct phenotype on cultured cells, characterized by
necrosis at concentrations of above 1 g/ml within 4 h and
delayed apoptosis at concentrations as low as 1 ng/ml within
24 h (1). In order to determine the activity of mycolactone F on
cultured cells, purified mycolactone was added to a semicon-
fluent layer of L929 fibroblasts and tested for the ability to
produce necrosis or apoptosis. Although mycolactone F showed
typical mycolactone phenotypes, the potency of mycolactone F
with regard to apoptosis was significantly less than that of
mycolactone A/B (Fig. 6).
DISCUSSION
For 25 years, M. ulcerans had the distinction of being the
only mycobacterial pathogen to produce a secreted toxin. The
finding that mycolactone is plasmid encoded led to the hypoth-
esis that other mycolactone-producing mycobacteria might ex-
ist, particularly in aquatic environments. Results from this in-
vestigation show that mycolactone-producing Mycobacterium
species are widely distributed within aquatic environments. It is
significant that all mycolactone-producing mycobacteria have
been identified as pathogens.
Although the ecology of M. ulcerans is poorly understood,
the only well-defined risk factor for infection is association with
slow-moving water (2, 3, 6, 35). Of particular interest is the fact
that human disease caused by M. ulcerans, frog disease caused
by M. liflandii, and fish disease caused by MPMM and M.
pseudoshottsii have been associated with deteriorating water
quality and/or eutrophic enrichment (2, 8, 24, 32). This sug-
gests that similar water quality parameters in different parts of
the world may play a role in the ecology of mycolactone-
producing bacteria. The geographic heterogeneity of mycolac-
tone structure, along with highly conserved structure within a
specific region, has led to the hypothesis that there is strong
selection within a specific environment for a particular myco-
lactone. The discovery of mycolactone F in two mycobacterial
species isolated from fish in widely separated geographic areas
suggests that mycolactone F plays a particular role in fish disease.
Fish may in fact act as “indicator species” in these environments.
Mycolactones are synthesized by large type 1 polyketide
synthases. There is a remarkable amount of repeated DNA
sequence within the mycolactone pks genes, which provides the
opportunity for formation of new mycolactones through re-
combination (29). However, the core lactone structure in my-
colactone F is identical to that in mycolactones from M. ulcer-
ans and M. liflandii. Mycolactone F is the smallest mycolactone
identified so far, and it varies from other mycolactones in side
chain structure. Our results suggest that side chain structure
plays an important role in potency, since the ability of myco-
lactone F to cause apoptosis is significantly less than that of
other mycolactones. In the past five years there has been an
intense search for M. ulcerans in the environment. Those stud-
ies have relied solely on detection of IS2404 as evidence for M.
ulcerans, based on a report showing that IS2404 was absent
from 48 species of mycobacteria obtained from a laboratory
collection (27). IS2404 PCR has been used to demonstrate the
presence of M. ulcerans DNA in fish (10), frogs, many species
of insects, snails, and a large range of aquatic samples from
Africa (19, 22). The presence of IS2404 in MPMM, along with
its presence in M. liflandii and M. pseudoshottsii, provides a
clear signal that IS2404 PCR cannot be used as the sole evi-
FIG. 5. Structural comparison of mycolactone A/B and mycolactone F.
VOL. 74, 2006 MYCOBACTERIAL FISH PATHOGENS MAKE A NOVEL MYCOLACTONE 6043
 o
n
 July 2, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
dence for M. ulcerans in environmental samples. Nonetheless,
IS2404 may be a useful marker for the mycolactone plasmid.
There is considerable heterogeneity within M. marinum spe-
cies (31, 35). In the past few years investigators have suggested
that M. marinum isolates from humans are genetically different
than isolates from poikilothermic species. Stinear et al. (28)
examined 22 M. marinum isolates (19 from humans and 3 from
fish) and used multilocus sequence analysis to separate them
into five categories. Based on an examination of 11 human
isolates and 6 fish isolates, Van der Sar et al. (35) suggested
that the human isolates were more pathogenic in zebra fish and
better able to grow in the human macrophage THP-1 cell line
than isolates from poikilothermic species such as fish. The
majority of these strains were from collections, and the country
of origin was not provided, making it impossible to compare
isolates within a geographic region. The best data for the
association of specific M. marinum genotypes with human or
nonhuman aquatic vertebrate strains comes from a report by
Ucko and Colorni (34) comparing 20 human isolates of M.
marinum with 12 fish isolates from the Red Sea. In that study,
human isolates were distinguished phenotypically and genotyp-
ically from fish isolates from the Red Sea in Israel. In our study
we further distinguish the Red and Mediterranean Sea fish
isolates from other groups of M. marinum strains by showing
that these isolates produce a mycolactone toxin. This work also
supports earlier studies describing discrete populations of M.
marinum strains in Israel (34).
Why is it that the vast majority of M. marinum strains do not
produce mycolactone? One possibility is that not all strains are
capable of acting as recipients for the mycolactone plasmid.
This is supported by the fact that MPMM strains form a group
distinct from other M. marinum isolates in Israel. An interest-
ing parallel may exist between Shigella species and mycolac-
tone-producing mycobacteria. Although it is convenient to
look at Shigella species as Escherichia coli with an invasion
plasmid, not all E. coli strains can act as recipients for the
plasmid. In particular, the loss of outer membrane proteins is
a prerequisite for conjugal competency. What are the host
requirements for horizontal transfer of the mycolactone plas-
mid? One possibility is that insertion of IS2404 in M. ulcerans,
MPMM, M. liflandii, and M. pseudoshottsii has resulted in loss
of membrane-associated genes, thus rendering them compe-
tent for horizontal transfer. Alternatively, these strains may
have acquired genes enabling horizontal transfer, although this
explanation would be inconsistent with molecular evidence
suggesting that M. ulcerans evolved from an M. marinum an-
cestor. Most of the studies on M. marinum and most of the
strains in collections are from infected humans. These strains
FIG. 6. Analysis of mycolactone-mediated cytopathicity. (A) Cytopathicity on L929 murine fibroblasts, showing untreated cells (left; total
magnification, 200) versus cells treated with 100 ng mycolactone A/B (middle; total magnification, 200) versus cells treated with 100 ng
mycolactone F (right; total magnification, 200). (B) Cytotoxicity measured by LDH release. Culture supernatants were collected from wells
containing L929 cells 4 h after mycolactone treatment, and the amount of LDH was measured using a CytoTox 96 assay kit (Promega). Data are
means and standard deviations of the values obtained from triplicate samples; P 	 0.05 for all concentrations (Student’s t test). (C) Apoptosis was
assessed at 24 h with the cell death detection enzyme-linked immunosorbent assay kit (Roche) and expressed as fold enrichment of nucleosomes.
Data are means and standard deviations of the values obtained from triplicate samples; P 
 0.05 for 15 ng, 150 ng, and 1.5 g (Student’s t test).
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may not be representative of M. marinum in its natural aquatic
environment. We cannot rule out the possibility that a more
thorough analysis of nonhuman M. marinum isolates might
show that MPMM are “typical” strains.
Given the importance of the mycolactone plasmid for viru-
lence of M. ulcerans, what is the likely virulence of MPMM and
M. pseudoshottsii for humans? Although mycolactone F is toxic
for human cells, this is relevant to human disease only if
MPMM or M. pseudoshottsii strains are capable of colonizing
mammalian species. The temperature-restricted growth of
MPMM and M. pseudoshottsii may well be a barrier to infec-
tion of mammalian species. However, mycolactone-producing
aquatic mycobacteria may provide a reservoir for genes impor-
tant for the evolution of new human pathogens.
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